Mar. Drugs 2012, 10(5), 1103-1125; doi:10.3390/md10051103
Article

Geographic Variability and Anti-Staphylococcal Activity of the Chrysophaentins and Their Synthetic Fragments

1 Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA 2 Center for Chemical Methodologies and Library Development, University of Pittsburgh, Pittsburgh, PA 15260, USA Current address: Department of Pharmaceutical Biotechnology, Saarland University, 66123 Saarbrücken, Germany.
* Author to whom correspondence should be addressed.
Received: 15 April 2012; in revised form: 5 May 2012 / Accepted: 7 May 2012 / Published: 22 May 2012
(This article belongs to the Special Issue Marine Anti-infective Agents)
PDF Full-text Download PDF Full-Text [1020 KB, Updated Version, uploaded 23 May 2012 14:22 CEST]
The original version is still available [1076 KB, uploaded 22 May 2012 14:45 CEST]
Abstract: Drug-resistant Staphylococcus aureus is a continuing public health concern, both in the hospital and community settings. Antibacterial compounds that possess novel structural scaffolds and are effective against multiple S. aureus strains, including current drug-resistant ones, are needed. Previously, we have described the chrysophaentins, a family of bisdiarylbutene macrocycles from the chrysophyte alga Chrysophaeum taylori that inhibit the growth of S. aureus and methicillin-resistant S. aureus (MRSA). In this study we have analyzed the geographic variability of chrysophaentin production in C. taylori located at different sites on the island of St. John, U.S. Virgin Islands, and identified two new linear chrysophaentin analogs, E2 and E3. In addition, we have expanded the structure activity relationship through synthesis of fragments comprising conserved portions of the chrysophaentins, and determined the antimicrobial activity of natural chrysophaentins and their synthetic analogs against five diverse S. aureus strains. We find that the chrysophaentins show similar activity against all S. aureus strains, regardless of their drug sensitivity profiles. The synthetic chrysophaentin fragments indeed mimic the natural compounds in their spectrum of antibacterial activity, and therefore represent logical starting points for future medicinal chemistry studies of the natural products and their analogs.
Keywords: chrysophaentins; Staphylococcus aureus; antibacterial

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Keffer, J.L.; Hammill, J.T.; Lloyd, J.R.; Plaza, A.; Wipf, P.; Bewley, C.A. Geographic Variability and Anti-Staphylococcal Activity of the Chrysophaentins and Their Synthetic Fragments. Mar. Drugs 2012, 10, 1103-1125.

AMA Style

Keffer JL, Hammill JT, Lloyd JR, Plaza A, Wipf P, Bewley CA. Geographic Variability and Anti-Staphylococcal Activity of the Chrysophaentins and Their Synthetic Fragments. Marine Drugs. 2012; 10(5):1103-1125.

Chicago/Turabian Style

Keffer, Jessica L.; Hammill, Jared T.; Lloyd, John R.; Plaza, Alberto; Wipf, Peter; Bewley, Carole A. 2012. "Geographic Variability and Anti-Staphylococcal Activity of the Chrysophaentins and Their Synthetic Fragments." Mar. Drugs 10, no. 5: 1103-1125.

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert